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Abstract
Background: The Human Microbiome has been variously associated with the immune-regulatory mechanisms
involved in the prevention or development of many non-infectious human diseases such as autoimmunity, allergy
and cancer. Integrative approaches which aim at associating the composition of the human microbiome with other
available information, such as clinical covariates and environmental predictors, are paramount to develop a more
complete understanding of the role of microbiome in disease development.
Results: In this manuscript, we propose a Bayesian Dirichlet-Multinomial regression model which uses spike-and-slab
priors for the selection of significant associations between a set of available covariates and taxa from a microbiome
abundance table. The approach allows straightforward incorporation of the covariates through a log-linear regression
parametrization of the parameters of the Dirichlet-Multinomial likelihood. Inference is conducted through a Markov
Chain Monte Carlo algorithm, and selection of the significant covariates is based upon the assessment of posterior
probabilities of inclusions and the thresholding of the Bayesian false discovery rate. We design a simulation study to
evaluate the performance of the proposed method, and then apply our model on a publicly available dataset
obtained from the Human Microbiome Project which associates taxa abundances with KEGG orthology pathways. The
method is implemented in specifically developed R code, which has been made publicly available.
Conclusions: Our method compares favorably in simulations to several recently proposed approaches for similarly
structured data, in terms of increased accuracy and reduced false positive as well as false negative rates. In the
application to the data from the Human Microbiome Project, a close evaluation of the biological significance of our
findings confirms existing associations in the literature.
Keywords: Bayesian hierarchical model, Data integration, Dirichlet-multinomial, Microbiome data, Variable selection
Background
The human microbiome is defined as the collection of
microorganisms, including bacteria, viruses, and some
unicellular eukaryotes, that live in and on our bodies [1].
Research on the microbiome has grown exponentially in
the past few years and it has been argued that the micro-
biota can be regarded as a “second genome”[2, 3]. Indeed,
just the human gut microbiome is estimated to be com-
posed of approximately 1014 bacterial cells, i.e. ten times
more than the total number of human cells in the body
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[4]. The contribution of the human microbiome on sev-
eral health outcomes has been frequently reported in the
literature. For example, microbial dysbiosis in the gut has
been linked to irritable bowel syndrome and Crohn’s dis-
ease [5], type 2 diabetes [6], cardiovascular disease [7], and
psychological conditions via the so-called “gut-brain axis”
[8]. The composition of microbiota at other body sites
have also been associated with conditions such as eczema
[9] and pre-term labor [10]. This stream of research holds
great potential for a better understanding of many mech-
anistic processes in the development of human diseases,
especially with respect to immune regulation and barrier
defense [11, 12].
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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Microbiome data is most commonly obtained by
sequencing variable regions of the 16S rRNA gene, then
grouping the transcripts into Operational Taxonomic
Units (OTUs), based on their similarity to one another.
The OTUs are then defined as a cluster of reads based on
a similarity threshold (typically, 97%) set by the researcher.
The membership count of each cluster is then used as a
proxy for taxa abundances in the sample [13]. See [14] for a
discussion of how the selection of the cutoff might impact
the resulting OTUs, in particular for rare species. Many
studies summarize the taxa abundances by construct-
ing several indicators of community composition (e.g.
alpha and beta diversity indexes, see, [15]). Alternatively,
the full OTUs abundance table can be used to obtain
more detailed information about existing associations
between environment or phenotypes and microbes. Well-
established statistical models for the analysis of count
data (e.g., Poisson or Negative Binomial distribution) can
be efficaciously employed for the analysis of taxonomic
count data [16]. Although less common, other distribu-
tions (e.g., a two-parameter Weibull distribution) have
also been shown to provide a good fit to the data for some
communities (see, e.g. [17]). One distinctive characteristic
of themicrobiome data is their overdispersion: while some
taxa (e.g., Bacteroides and Lactobacillus species) are com-
mon among samples, many other taxa are present at much
lower abundances, and often never recorded in a sample,
leading to zero-inflated distributions. Many of the existing
tools for microbial community analysis (e.g., the QIIME
platform, [18]) bypass those characteristics and rely on
nonparametric tests to compare species across different
conditions [19, 20]. Other approaches use ordination, e.g.
multidimensional scaling, to summarize abundances, and
are sometimes employed to link the microbiome data with
available clinical covariates and phylogenetic information
[21, 22]. In those approaches, the choice of the distance
metric is often crucial. The interpretation of biological
phenomena can also be challenging in low dimensional
projections. Most importantly, distance-based methods
do not explicitly quantify the relative importance of sig-
nificant associations between taxa and covariates, and
therefore are of limited use for clinical decisions.
In this manuscript, we consider an integrative Bayesian
approach based on the use of Dirichlet-Multinomial (DM)
distributions [23] for studying the association between
taxa abundance data and available measurements on clin-
ical, genetic and environmental covariates. Recently, La
Rosa et al. [24] proposed the use of a DM model for
hypothesis testing and power calculations in microbiome
experiments. Holmes et. al [25] used a finite mixture of
DM distributions to directly model the taxa counts. Nei-
ther method incorporate predictors to study the influence
of external factors on the microbiome’s abundance. A
penalized likelihood approach based on a DM regression
model has been proposed instead by [26] to determine
significant associations between the microbiome compo-
sition and a set of covariates which describe the individual
dietary nutrients’ intakes. Similarly, [27] develop a struc-
ture constrained version of sparse canonical correlation
analysis that integrates compositionalized microbiome
data, phylogenetic information, and nutrient information.
Furthermore, [28] propose penalized regression models
to associate the multivariate compositionalized micro-
biome data with some univariate phenotype of interest,
e.g. body mass index, as a response. However, the use
of a constrained optimization approach does not allow
to fully characterize the uncertainty in the selection of
the significant associations, which is of particular impor-
tance, especially when dealing with high-dimensional and
highly-correlated data.
Here, we propose a probabilistic modeling approach
which both flexibly takes into account the typical features
of microbiome count data and also allows for straight-
forward incorporation of available covariate informa-
tion within a DM log-linear regression framework. With
respect to modeling approaches as in [28], our frame-
work allows the study of associations between multi-
variate microbiome data and multivariable predictors. By
imposing sparsity inducing spike-and-slab priors on the
regression coefficients, our model obtains a parsimonious
summary of the effects of the associations and also allows
an assessment of the uncertainty of the selection process.
We evaluate the performance of our model first on simu-
lated data, where we provide comparisons with methods
developed for microbiome or similar type of data. We also
illustrate our method on data obtained from the Human
Microbiome Project [29], to investigate the association
between taxonomic abundances and metabolic pathways
inferred from whole genome shotgun sequencing reads. It
is known that the combination of environmental and host
genetic factors shape the composition of the gut micro-
biota, and these interactions appear to have a significant
effect on several biological mechanisms, which may be
related, for example, to the individual immunity and bar-
rier defense, as well as metabolism and diet [30, 31]. The
approach has been implemented in a user-friendly R code,
which has been made publicly available (see the Licensing
Section).
Methods
We describe our Bayesian variable selection approach for
the analysis of microbiome data and their association with
a set of available covariates in the context of DM log-linear
regression models.
Dirichlet-multinomial regression with variable selection
Let yi = (yi1, . . . , yiJ ) indicate the vector of counts rep-
resenting the taxonomic abundance table obtained from
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the ith patient, with yij denoting the frequency of the jth
microbial taxon, for j = 1, . . . , J and i = 1, . . . , n. Fur-
thermore, let X = (x1, . . . , xP) indicate a n × P matrix of
measurements on P covariates. We start by modeling the
taxonomic count data with a Multinomial distribution
yi | φi ∼ Multinomial
(
yi+,φi
)
, (1)
with yi+ = ∑Jj=1 yij the summation of all counts in the
vector, and where the parameters φ’s are defined on the J
dimensional simplex
S J−1 =
{(
φ1, . . . ,φJ
)
: φj ≥ 0, ∀j, ∑Jj=1 φj = 1
}
,
We further impose a conjugate Dirichlet prior on φ, that
is φ ∼ Dirichlet(γ ), where γ = (γ1, . . . , γJ ) indicates a
J-dimensional vector of strictly positive parameters. An
advantage of our hierarchical formulation is that conju-
gacy can be exploited to integrate φ out, obtaining the
Dirichlet–Multinomial model, yi ∼ DM(γ ), with proba-
bility mass function
f (y | γ ) =  (y+ + 1)  (γ+)
 (y+ + γ+)
×
J∏
j=1

(
yj + γ+
)
(γj)
(
yj + 1
) .
where γ+ = ∑Jj γj. First described in [23] as the com-
pound multinomial, the DM(γ ) allows more flexibility
than the Multinomial when encountering overdispersion
in multivariate count data, as it induces an increase in the
variance by a factor of (y+ + γ+)/(1 + γ+).
Next, we incorporate the covariates into the model-
ing via a log-linear regression framework where the DM
parameters depend on the available covariates X’s. More
specifically, we define ζj = log(γj) and assume
ζj = αj +
P∑
p=1
βpj xp, (2)
i = 1, . . . , n; j = 1, . . . , J . In this formulation, the intercept
term αj corresponds to the log baseline parameter for the
taxon j, whereas the regression parameter βpj captures the
effect of the pth covariate on the abundance for that taxon.
Identifying the significant associations between taxa
and covariates in model (1)–(2) is equivalent to determin-
ing the non-zero βpj parameters. One way to address this
issue is through variable selection and the use of spike-
and-slabmixture priors [32, 33]. First, we introduce latent
binary indicator vectors ξ j = (ξ1j, ξ2j, . . . , ξpj), such that
ξpj = 1 if the pth covariate influences the abundance of the
jth taxa and ξpj = 0 otherwise. Then, we write the prior
on the βpj’s as
βpj ∼ ξpjN
(
0, r2j
)
+ (1 − ξpj
)
δ0
(
βpj
)
, (3)
where δ0 denotes a Dirac-delta at 0 and r2j is some suit-
ably large value [34, 35]. It is common to choose relatively
large values for r2j . Such a choice suggest a flat prior dis-
tribution on the location of the coefficients {βpj | ξpj = 1}
and therefore encourages the selection of relatively large
effects. In the Results Section, we discuss the results of a
sensitivity analysis to assist with the choice of this param-
eter. We place Bernoulli priors on the selection indicators
ξpj, that is
π
(
ξ j | pj
)
=
P∏
p=1
pξpjpj
(
1 − ppj
)1−ξpj . (4)
We also specify Beta hyperpriors on the hyperparam-
eters ppj, i.e., ppj ∼ Beta(a, b), as this has been shown
to provide an automatic adjustment for multiplicity [36].
This is equivalent to placing a Beta mixed Binomial distri-
bution on ξpj,
π
(
ξpj
) =
∫
π
(
ξpj | λ
)
π(λ)dλ,
with λ = (a, b). As a practical suggestion, the hyper-
parameters a and b should be chosen so to induce a
relatively weakly specification of the prior as a “flat” Beta
distribution. This can be obtained by setting a and b so
that a + b = 2, and the prior expected mean value
m = a/(a + b). For most cases, a value of m = 0.01,
which corresponds to assuming a priori that 1% of the
P covariates will be selected, provides an adequate bal-
ance between false positives and false negative counts,
as we further illustrate in a sensitivity analysis in the
Results Section. Finally, we assume normal priors on the
αj’s, i.e. αj ∼ N (0, s2j ). Large values for s2j encode a dif-
fuse prior, to describe non-informative or objective prior
beliefs. However, results are typically quite robust to prior
choices on the intercept parameters, and s2j = 10 is usually
assumed as a default specification in Bayesian regression
when dealing with standardized variables. Figure 1 pro-
vides an overview of the proposed integrative modeling
approach, with reference to the application to the Human
Microbiome Project data we describe later.
MCMC algorithm
We implement a stochastic search Markov Chain Monte
Carlo (MCMC) algorithm for posterior inference that
employs a Gibbs scan to sample the non-zero regression
coefficients [37]. We encourage an efficient sampling by
employing a component-wise adaptive Metropolis algo-
rithm [38] as described below. A generic iteration of the
MCMC algorithm comprises the following steps:
1. Update of α: This is a Metropolis-Hastings step with
a symmetric random walk proposal α′j ∼ N (αj, t2α),
for j = 1, . . . , J .
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Fig. 1 Schematic overview of the proposed integrative Bayesian approach for the application to data from the Human Microbiome Project. The
observed data counts (right) are regressed on the available covariates (left), through a variable selection approach, which informs the (unknown)
population abundance of each taxon
2. Joint update of (ξ ,β):We sample these parameters
jointly via a Gibbs scan that employs a Metropolis
acceptance step. For each j = 1, . . . , J and
p = 1, . . . ,P:
• if ξpj = 1: propose ξ ′pj = 0 and β
′
pj = 0.
• if ξpj = 0: propose ξ ′pj = 1 and then propose β
′
pj
following an adaptive Metropolis-Hasting
scheme
β
′
pj ∼ 0.95N
(
βpj, 2.382 × σˆ 2βpj/J × P
)
+ 0.05N (βpj, 0.01/J × P
)
,
where σˆ 2βpj is the current estimate of the
variance of the target distribution. The value of
σˆ 2βpj is updated using a recursive formula as in
[39] on all the previous draws for βpj.
• Accept (ξ ′pj,β
′
pj) with probability
a = min
⎧
⎨
⎩
1,
π
(
ξ
′
pj,β
′
pj | ξ
′
pj,β
′
pj, else
)
π
(
ξpj,βpj | ξ ′pj,β ′pj, else
)
⎫
⎬
⎭
,
where ξ ′pj = (ξ ′1,j, . . . , ξ
′
p−1,j, ξp+1,j, . . . , ξpj), and
β
′
pj = (β ′1,j, . . . ,β
′
p−1,j,βp+1,j, . . . ,βpj).
For posterior inference, we are interested in identify-
ing the relevant associations between taxa and covariates
as captured by the selection indicators ξpj’s and the cor-
responding regression coefficients βpj’s. Estimates of the
marginal posterior probabilities of inclusion (PPIs) of the
latent indicators ξpj can be calculated by counting the
number of times that each taxa/covariate association is
included across the MCMC iterations. A selection of
the significant associations can then be made by choos-
ing those elements that have marginal PPIs greater than
a specific value, for example greater than 0.5 for the
median probability model of [40]. Another choice for the
threshold which controls for multiplicity [41] relies on
an estimated pre-specified Bayesian false discovery rate α
calculated as
F̂DR(c) =
∑P
p=1
∑J
j=1
(
1 − P̂PIpj
)
Dpj
∑P
p=1
∑J
j=1 Dpj
,
where Dpj = 1(P̂PIpj > c). An optimal threshold c′
can be found for error rate α by choosing c′ such that
F̂DR(c′) < α. Estimates of the non-zero regression coef-
ficients βpj can also be calculated by averaging over the
sampled MCMC values.
In order to compare selection performance of different
methods, we calculate accuracy, false positive rate (FPR),
false negative rate (FNR) and Matthews correlation coef-
ficient (MCC), across 30 replicated datasets. We define
accuracy as ACC= (TP+TN)/(P+N), with TP the num-
ber of true positives out of P selected and TN the number
of true negatives out of N not selected. The false nega-
tive rate is calculated as FNR = FN/(FN + TP), the false
positive rate as FPR = FP/(FP + TN), and the Matthews
correlation coefficient as
MCC = MCC = TP/N − S × P√
PS(1 − S)(1 − P) ,
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with N = TN+TP+FN+FP, P = TP+FPN and S = TP+FNN
[42]. Since the MCC balances TP and FP counts, and
can be used even if the classes are of very different sizes,
it is generally regarded as one of the most appropriate
measures of classification accuracy. We further computed
receiving operating curves (ROC) to compare the per-
formance of the selection procedure across the different
methods.
Comparison study on simulated data
We carry out a simulation study to assess the perfor-
mance of our model and compare results to alternative
methods. More specifically, we consider two methods
which have been specifically employed for the integrative
analysis of microbiome data: the penalized approach of
Chen and Li [26], and the false discovery rate-corrected
pair-wise correlation tests considered in [19]. In addi-
tion, we consider the factorized maximum a posteriori
(MAP) Bayesian lasso of [43], a recently proposed gen-
eral statistical method for conducting variable selection in
multivariate count-response regression. When fitting the
Bayesian Gamma Lasso method of [43], model selection
was done using the minimum AIC, while for Chen and
Li’s approach the minimum BIC was calculated with the
group penalty set to 20%. We also fit the method of Chen
and Li to the untransformed data. The false discovery
rate threshold for the Spearman’s correlation tests was set
to 0.05.
In simulating data, we set n = 100, P = 50 and
J = 50, and chose Pr = 9 and Jr = 5 to obtain a total
number of relevant taxa/covariate associations equal to
25. We simulated the covariate matrix X according to a
Multivariate-Normal(0,) with i,j = ρ|i−j| and ρ =
0.4. We drew each vector yi of counts from a Dirichlet-
Multinomial distribution as follows. For i = 1, . . . , n,
yi ∼ Multinomial(Ni,π∗i ), with the row sum Ni ∼
DiscreteUnif[ 1, 0000; 2, 000], and π∗i = (π∗i1, . . . ,π∗iJ ) ∼
Dirichlet(γ ∗). For γ ∗ = (γ ∗1 , . . . , γ ∗J ), we set γ ∗j =
γj
γ+
1−ψ
ψ
, j = 1, . . . , J , with γj = exp{αj + Xβ j}, γ+ =
∑J
j=1 γj and ψ ∈ [0, 1] an overdispersion parameter.
When ψ → 0, the simulated values approximate a
Multinomial(π) distribution, while for large ψ , the sam-
pled values are more disperse. Here, we set ψ = 0.01. We
sampled the non-zero βpj’s from the intervals ±[0.5, 1.0]
and the intercept parameters from a Uniform(–2.3, 2.3).
Below we report performance results as averages over 30
replicated simulated datasets.
When running the MCMC, we used a vague prior for
the intercept by setting the variance parameter to s2pj = 10.
Similarly, we set r2pj = 10, to provide sufficiently vague
prior information on the non-zero log-linear regression
coefficients. Finally, we set m = 0.01 (or a = 0.02 and
b = 1.98), resulting in a sparse prior mean on selected
associations of 1% of the total. We provide comments on
the sensitivity of the selection results to the choice of
these hyperparameters in the Section below. We ran the
MCMC algorithm for 10,000 iterations and thinned to
every fifth iteration. On a single dataset, the C code took
approximately 31.5 min to run on an Intel Xeon E5-2630
2.30GHz processor.We assessed convergence visually and
via the Geweke diagnostic [44] as implemented in the R
package coda. Convergence was checked for a) the num-
ber of active variables in each iteration and b) the samples
from each of the selected βpj. The five number sum-
mary of the 25 Geweke z-scores was (–3.43, –1.06, –0.63,
0.71, 1.98).
Inferring associations between taxonomic abundances and
metabolic pathways
We demonstrate our approach on publicly available data
obtained from the Human Microbiome Project (HMP)
website [29] from which we use 79 samples from healthy
individuals. The Y matrix in our model contains 16S
rRNA microbial counts from stool samples at the genus
taxonomic level. As common in microbiome studies, the
genera abundances (Bacteroides, Prevotella , etc.) were fil-
tered by requiring each genus to be present in at least 5%
of the samples. This procedure removes extremely low-
abundance genera leaving 80 genera for the analysis. From
the same 79 individuals, we obtained KEGG orthology
group abundances which are used as the matrix of covari-
ates X of our model. The KEGG orthology groups were
reconstructed from metagenomic shotgun sequencing
(WGS) using the HMP Unified Metabolic Analysis Net-
work (HUMAnN) pipeline [45] and were also provided on
the HMP website. These values represent inferred abun-
dances of biochemical functional groups and metabolic
pathways present due to the shotgun sequenced reads of
bacterial and non-bacterial genes in the sample. To reduce
correlation among the covariates we used average link-
age clustering on the correlation matrix of the KEGG
groups and chose one representative from each cluster,
according to its relevance to microbiome research, leav-
ing 76 columns in X. Finally, the columns in X were mean
centered and scaled to unit variance. Though the HMP
sampled 300 individuals for several timepoints and over
many sites, there were relatively few samples that included
the WGS used to obtain the KEGG orthology data. Thus,
when joining the samples from the 16S rRNA data and
the KEGG orthology data, a total of 79 matched samples
remained.
We used the same hyperparameter settings as in the
simulation study, that is s2pj = 10 and r2pj = 10 and set
m = 0.01, resulting in a sparse mean selection prior of
1% of the total 6,080 possible associations. The MCMC
algorithm described in “MCMC algorithm” section above
was run for 500,000 iterations and thinned to every
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100th draw. We assessed convergence visually and via
the Geweke diagnostic [44] as implemented in the
R package coda. The five number summary of the
Geweke z-scores for the 26 βpj’s was (–3.83, –1.19, 0.15,
1.46, 3.38).
Results
Simulation study
In Fig. 2 we show the plot of the marginal PPIs of the P ×
J elements ξpj, obtained by computing the proportion of
times that ξpj = 1 across all iterations, after burn-in. The
selected median model, corresponding to a threshold of
0.5 on the PPIs, results in a false positive rate of 0.0004 and
a false negative rate of 0.04. The value of the AUC for this
replicate was 0.99.
Figure 3 illustrates the selection performance of the
proposed method, by plotting the average ROC curves
over the 30 replicated datasets (ψ = 0.01) for each
of the methods included in the comparison. The Figure
shows that our proposed model outperforms the compet-
ing methods in terms of achieved average true and false
positive rates.
As an additional comparison, together with the total
number of correctly identified regression parameters,
which we term “overall recovery”, we also looked at the
“taxa-wise recovery”, which we defined as the correct
recovery of any element from one of the J taxa. Thus,
recovery for overall selection occurs for P × J elements
while taxa-wise selection occurs for J elements. Table 1
reports average values for accuracy, FPR, FNR and MCC,
averaged across the 30 replicated datasets, for both over-
all and taxa-wise recovery. These results show that our
method in particular outperforms competing methods for
taxa-wise recovery. In the same Table we report results
for a more challenging simulated scenario, obtained with
a higher value of the overdispersion parameter (ψ = 0.1).
As expected, the increase in overdispersion makes the
selection task more difficult for all methods. However, our
method still outperforms or is commensurate with the
competing methods, even in the presence of considerable
overdispersion.
Sensitivity analysis
Since our proposal requires the choice of a number of
hyperparameters, it is important to investigate how sen-
sitive the results are to varying parameter sets. Therefore,
we conclude our simulation study by briefly discussing
the sensitivity of the results to the prior specifications.
In general, we found that results were robust to the
prior choices on the intercept parameters, αj, while, as
expected, some sensitivity was observed with respect to
the variance hyperparameters of the spike-and-slab prior
(3) on the regression coefficients, βpj, and the hyperpa-
rameters of the Beta priors on ppj. In Table 2 we report
results obtained by considering a full grid of values for the
prior expected value of ppj, i.e.m ∈ {0.005, 0.01, 0.05}, and
the slab variance, r2pj ∈ {1, 10, 100}. In the Additional file 1,
we further report the corresponding ROC curves. With
only 25 truly non-zero βpj’s, out of 2,500 parameters, small
increases in false positive rates can drastically decrease the
Matthews correlation coefficient. Thus imposing some
sparsity by using a smaller value for m improves overall
performance while larger values of m allow for more false
positives. The results appear to suggest that assuming
moderate sparsity a priori (e.g., m = 0.01) generally leads
to good operating characteristics. Similarly, when the slab
variance is small, e.g. r2pj = 1, there is more prior density
close to zero, which allows small but insignificant vari-
ables to be selected. Conversely, when the slab variance is
large, e.g. r2pj = 100, false positives are less likely but false
negatives increase, since the prior density is spread more
evenly over the support. Therefore, an intermediate value,
e.g. r2pj = 10, provides a reasonable compromise, which
favors relatively large effect sizes and a small number of
false positives. In the Additional file 1, we also report
the performance of our method for varying values of the
over-dispersion parameter ψ and the sample size n. As
Fig. 2 Simulated data: Marginal posterior probabilities of inclusion (PPI) for each coefficient β jp, j = 1, . . . , 50, p = 1, . . . , 50, describing the
association between each taxa and each covariate. Each PPI is obtained by averaging the number of times that each taxa/covariate association is
included across the MCMC iterations, after burn-in. The true associations are indicated as red dots
Wadsworth et al. BMC Bioinformatics  (2017) 18:94 Page 7 of 12
ROC Curves
Average false positive rate
A
ve
ra
ge
 tr
ue
 p
os
iti
ve
 r
at
e
0.0 0.2 0.4 0.6 0.8 1.0
0.
5
0.
6
0.
7
0.
8
0.
9
1.
0
DMBVS (AUC = 0.997)
MAPBL (AUC = 0.959)
CORTEST (AUC = 0.785)
C&L (AUC = 0.949)
Fig. 3 Simulated data: Comparison results of selection performances (ROC curves). DMBVS: Dirichlet–Multinomial Bayesian Variable Selection (our
method), MAPBL : Maximum A Posteriori Bayesian Lasso, CORTEST: Multiplicity Corrected Correlation Tests as in Wu et al. (2010), C&L: composite
penalty from Chen and Li (2013)
expected, the results show that the performances improve
for larger sample sizes and decreasing overdispersion.
Data analysis
Figure 4 shows the traceplot of the number of included
taxa/covariate associations and the plot of the marginal
PPIs of the P × J elements ξpj, obtained by comput-
ing the proportion of times that ξpj = 1 across all
iterations, after burn-in. Here the median model, corre-
sponding to a threshold of 0.5 on the PPIs, selects 92
associations. Among those, 26 have a marginal PPI greater
than 0.98, which corresponds to a Bayesian FDR of 0.1.
These 26 associations are listed in Table 3, together with
the corresponding estimated regression coefficients, and
depicted in Figs. 5 and 6, for positive and negative asso-
ciations, respectively. In these Figures, the magnitude of
the association, as captured by the estimated βpj’s, is
proportional to the width of the edges, with red lines
indicating negative associations and blue lines positive
associations. As a comparison, the method by Chen and
Li [26] identified 120 associations, whereas the Bayesian
Lasso of [43] and the correlation test-basedmethod of [19]
Table 1 Simulated data: performance assessment for two different scenarios, characterized by different values of the dispersion
parameter ψ
Overall Taxa
DMBVS MAPBL C&L CORTEST DMBVS MAPBL C&L CORTEST
ψ = 0.01
MCC 0.93 0.64 0.67 0.73 0.89 0.66 0.50 0.85
FNR 0.05 0.10 0.12 0.31 0.00 0.46 0.43 0.02
FPR 0.00 0.01 0.01 0.00 0.05 0.01 0.09 0.06
Accuracy 1.00 0.99 0.99 1.00 0.96 0.91 0.85 0.95
ψ = 0.1
MCC 0.72 0.42 0.54 0.56 0.73 0.40 0.38 0.70
FNR 0.39 0.58 0.28 0.63 0.24 0.73 0.52 0.37
FPR 0.00 0.01 0.01 0.00 0.05 0.01 0.12 0.02
Accuracy 1.00 0.99 0.99 1.00 0.92 0.86 0.81 0.92
Values are rounded averages over thirty replicates. Results for Matthews’ Correlation Coefficient, Falso Positive Rate, False Negative Rate, and Accuracy, are based on the
median probability model. DMBVS: Dirichlet–Multinomial Bayesian Variable Selection (our method), MAPBL: Maximum A Posteriori Bayesian Lasso, C&L: composite penalty
from Chen and Li (2013), CORTEST: Multiplicity Corrected Correlation Tests as in Wu et al. (2010)
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Table 2 Simulated data: sensitivity analysis for varying values of the prior expected value of ppj ,m, and the slab variance r2pj , and for
two different scenarios, characterized by different values of the dispersion parameter ψ
m = 0.005 m = 0.01 m = 0.05
r2pj = 1 r2pj = 10 r2pj = 100 r2pj = 1 r2pj = 10 r2pj = 100 r2pj = 1 r2pj = 10 r2pj = 100
ψ = 0.01
MCC 0.69 0.93 0.96 0.69 0.93 0.95 0.69 0.93 0.95
FPR 0.01 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00
FNR 0.02 0.04 0.08 0.02 0.05 0.09 0.02 0.05 0.08
Accuracy 0.99 1.00 1.00 0.99 1.00 1.00 0.99 1.00 1.00
AUC 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
ψ = 0.1
MCC 0.53 0.73 0.72 0.53 0.73 0.71 0.52 0.73 0.72
FPR 0.01 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00
FNR 0.26 0.37 0.46 0.26 0.37 0.47 0.26 0.37 0.47
Accuracy 0.99 1.00 1.00 0.99 1.00 1.00 0.99 1.00 1.00
AUC 0.96 0.96 0.93 0.96 0.96 0.93 0.95 0.95 0.93
Values are averages over 30 replicates
identified, respectively, 220 and 711 associations. Those
results appear to confirm the sparser selection achieved
by our method, consistently with the results of the
simulation study.
Discussion
A close investigation of the biological significance of
the associations identified by our model reveals several
interesting characteristics and affirms the relevance of
these associations. Commensal microbiota that inhabit
the human gut are proficient at scavenging glycans
and polysaccharides, including those in plants, such
as starches or cellulose, animal-derived tissues (gly-
cosaminoglycans and N-linked glycans), and glycans from
host mucus (O-linked glycans) [46]. Ruminococcus spp.
are known to participate in both resistant starch and gly-
cosaminoglycan degradation [46, 47]. It has been reported
that long-term consumption of diets rich in protein
and animal fat were associated with an enterotype pri-
marily containing increased Bacteroides and Ruminococ-
cus species [19]. Additionally, Ruminococcus torques
and Ruminococcus gnavus have been shown to degrade
mucins [48]. Thus, it is logical that Ruminococcus, which
is one of the noteworthy genera involved in glycosamino-
glycan degradation, would be negatively associated to
glycosaminoglycan biosynthesis (ko00534) (Table 3). Sim-
ilarly, Parabacteroides which is also negatively associated
with N-glycan biosynthesis (ko00513), is involved in deg-
lycosylation and utilization of N-glycans [49]. Also, among
the associations identified for the glycan pathways, Pre-
votella was negatively associated with mucin type O-
glycan biosynthesis (ko00512). In the literature, Prevotella
has implications for mucosal homeostasis, as some Pre-
votella spp. express a unique mucin-desulfating glycosi-
dase that can hydrolyze GlcNAc residues on mucin-type
O-glycans, and thus is important for mucin degradation
0 1000 2000 3000 4000 5000 6000
0.
0
0.
4
0.
8
taxa/covariate parameter index
P
P
I
Fig. 4 Real data: Marginal posterior probabilities of inclusion (PPI) for each coefficient β jp, in Eq. (2), describing the association between each taxa
and each covariate. Each PPI is obtained by averaging the number of times that each taxa/covariate association is included across the MCMC
iterations, after burn-in. Here, the median model, corresponding to a threshold of 0.5 on the PPIs, selects 92 associations. Among those, 26 have a
marginal PPI greater than 0.98, which corresponds to a Bayesian FDR of 0.1. These 26 associations are indicated as red dots
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Table 3 Real data: selection results using a BFDR of 0.1
KEGG ID Pathway Taxa MPPI βpj
ko04660 T cell receptor signaling pathway g.Subdoligranulum 1.00 0.40
ko04512 ECM-receptor interaction g.Subdoligranulum 1.00 0.44
ko00680 Methane metabolism g.Sutterella 1.00 -1.47
ko05200 Pathways in cancer o.Bacteroidales 1.00 -1.04
ko04540 Gap junction o.Bacteroidales 1.00 -0.92
ko00534 Glycosaminoglycan biosynthesis g.Ruminococcus 1.00 -0.56
ko00053 Ascorbate and aldarate metabolism g.Ruminococcus 1.00 -0.46
ko00650 Butanoate metabolism g.Ruminococcus 1.00 -0.55
ko00513 Various types of N-glycan biosynthesis g.Parabacteroides 1.00 0.54
ko00500 Starch and sucrose metabolism g.Parabacteroides 1.00 -0.61
ko00904 Diterpenoid biosynthesis g.Dialister 1.00 -1.21
ko00360 Phenylalanine metabolism g.Dialister 1.00 -2.18
ko00626 Naphthalene degradation g.Bacteroides 1.00 0.39
ko00010 Glycolysis / Gluconeogenesis g.Bacteroides 1.00 -0.57
ko00513 Various types of N-glycan biosynthesis g.Prevotella 1.00 0.77
ko00512 Mucin type O-Glycan biosynthesis g.Prevotella 1.00 -1.06
ko00620 Pyruvate metabolism g.Prevotella 1.00 -1.76
ko04340 Hedgehog signaling pathway g.Ruminococcus 1.00 0.45
ko04660 T cell receptor signaling pathway g.Roseburia 1.00 0.46
ko00983 Drug metabolism g.Sutterella 1.00 -1.20
ko00260 Glycine, serine and threonine metabolism o.Bacteroidales 1.00 0.88
ko00330 Arginine and proline metabolism g.Ruminococcus 0.99 0.39
ko01057 Biosynthesis of type II polyketide products o.Bacteroidales 0.99 0.76
ko00620 Pyruvate metabolism g.Ruminococcus 0.99 0.56
ko00920 Sulfur metabolism f.Prevotellaceae 0.99 1.36
ko00010 Glycolysis/Gluconeogenesis o.Clostridiales 0.98 0.54
The text in the KEGG column is hyperlinked to the KEGG orthology database for a more complete description of the selected pathways. Taxa names start with “g.”, “f.” or “o.”
which stand for genus, family, or order, respectively, and correspond to the lowest taxonomic classification available
Positive Associations (MPPI > 0.981)
ko00920
ko00513
ko00260
ko04660
ko00626
ko00620
ko01057
ko04512
ko04340
ko00330
f.Prevotellaceae
g.Parabacteroides
g.Prevotella
o.Bacteroidales
g.Roseburia
g.Subdoligranulum
g.Bacteroides
g.Ruminococcus
Fig. 5 Real data: Selected positive taxa-by-covariate associations. The
magnitude of the association, as captured by the median of the
MCMC draws for each βpj , is proportional to the width of the edges
Negative Associations (MPPI > 0.981)
ko00680
ko00512
ko00904
ko00500
ko00620
ko00010
ko00534
ko05200
ko00053
ko04540
ko00650
ko00983 g.Sutterella
g.Prevotella
g.Dialister
g.Parabacteroides
g.Bacteroides
g.Ruminococcus
o.Bacteroidales
Fig. 6 Real data: Selected negative taxa-by-covariate associations. The
magnitude of the association, as captured by the median of the
MCMC draws for each βpj , is proportional to the width of the edges
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[50].Other associations affirmed through the literature
included that of Bacteroides with naphthalene degrada-
tion (ko00626). It has been reported that Bacteroidetes
possess the capability to degrade polycyclic aromatic
hydrocarbons such as naphthalene [51]. Associations
of Ruminococcus with pyruvate metabolism (ko00620)
are also supported, as phosphoenolpyruvate carboxyk-
inase was previously reported to be associated with
Ruminococcus flavefaciens in the rumen [52]. Another
supported association is that of Prevotellaceae with sul-
fur metabolism. L-cysteine desulfhydrase enzymes have
been characterized in Prevotella intermedia [53]. Addi-
tionally, glycosulfatase enzymes have been described in
Prevotella [54]. Equally interesting is the selection of path-
ways that are expected to be omnipresent among many
bacteria, such as glycolysis/gluconeogenesis (ko00010), as
glycolysis occurs, with variations, in nearly all organisms,
both aerobic and anaerobic. Thus, it is not surprising that
taxa like Clostridiales are positively associated with gly-
colysis/gluconeogenesis as they are abundant taxa within
the gut microbiome.
Given the complexity of metabolic pathways and the
process of mapping specific genes to pathways, some of
the selected associations are unexpected, and might be
due to the 16S abundances that were made available at
the HMP site and the mapping of metagenomic sequences
to specific KEGG orthology groups by HUMAnN. For
example, several species of Ruminococcus are known to
participate in butanoate (butyrate) metabolism [55], Dial-
ister spp. have phenylalanine arylamidase activities [56],
and Prevotella spp. are known to participate in pyru-
vate metabolism [57, 58]. Since those associations should
be driven exclusively by bacterial genes, it is interesting
that we find significant associations between the abun-
dance of certain bacterial taxa and KEGG pathways that
are primarily reported among eukaryotic species (i.e., T-
cell receptor signaling, hedgehog signaling, pathways in
cancer, etc.). Indeed, although precautionary steps are
performed, the HMP consortium reported that human
contaminants are found in 50–90% of the sequences [15].
This might also explain the negative association exhib-
ited by Bacteriodes and glycolysis/gluconeogenesis . These
unexpected findings suggest the need for further investi-
gations and validation.
Conclusion
Herein, we have developed a Bayesian approach to the
Dirichlet-Multinomial regression models that allows for
the selection of significant associations between covari-
ates and taxa from a microbiome abundance table by
imposing spike-and-slab priors on the log-linear regres-
sion coefficients of the model. We have applied our
model to simulated data and compared performances
with methods developed for similar applications. We
have illustrated the performance of our method using
publicly available data on taxonomic abundances and
metabolic pathways inferred from whole genome shotgun
sequencing reads, which we obtained from the Human
Microbiome Project website. Our results have revealed
interesting links between specific taxa (i.e. genera) and
particular metabolic pathways, which we have validated
via existing literature.
Several extensions of our model are possible. Because
some habitats, e.g. the gut, are thought to have highly
variable dynamics, longitudinal sampling may be pre-
ferred to cross-sectional sampling since it may give a
better sense of long-term trends [59]. Thus, incorporat-
ing repeated samples with specified correlation structures
in the linear predictor could produce additional insights.
Another important aspect of microbiome data, which is
receiving attention from researchers, is the heterogene-
ity in community structure across samples, as this can
be an indication of the existence of “enterotypes” [60,
61]. This can be addressed within our modeling frame-
work by employing Bayesian nonparametric models that
would allow to cluster selected associations across parti-
tions of the samples. These extensions are currently under
investigation.
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